Drug intelligence / Profile preview

methylprednisolone + prednisone (Astellas Pharma)

Development stage
Unknown
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Methylprednisolone and prednisone are synthetic glucocorticoid corticosteroids used primarily for their potent anti-inflammatory and immunosuppressive properties. In the context of solid organ transplantation, such as kidney transplants, they are often used as part of a multi-drug immunosuppressive regimen (e.g., with tacrolimus and mycophenolate mofetil) to prevent acute and chronic graft rejection. They function by binding to the cytosolic glucocorticoid receptor, which then translocates to the nucleus to modulate gene expression, leading to the inhibition of pro-inflammatory cytokines and the suppression of T-cell activation and proliferation. In clinical protocols like the OSAKA trial, methylprednisolone is typically administered intravenously in the immediate post-operative period, followed by a transition to oral prednisone for long-term maintenance immunosuppression.

Brand names
MedrolDeltasoneSolu-MedrolRayosDepo-Medrol
Other names
methylprednisolone / prednisonesteroidscorticosteroidsglucocorticoids
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on methylprednisolone + prednisone (Astellas Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylprednisolone + prednisone (Astellas Pharma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call